Deal is expected to strengthen Nihon Kohden’s technical development capabilities.
Nihon Kohden, a global leader in precision medical products and services, has acquired Advanced Medical Predictive Devices, Diagnostics and Displays Inc. (AMP3D), owners of a vast library of clinical predictive algorithms and a unique software-as-a-service (SaaS) platform. AMP3D’s CoMET (Continuous Monitoring of Event Trajectories) decision support software utilizes patients’ continuous monitoring data, vital signs, medical records, and laboratory tests to display the patients’ real-time and continuous risk trajectories. Nihon Kohden Digital Health Solutions, Inc. (NKDHS) sees the benefit of this SaaS offering and plans to integrate the software into their healthcare ecosystem. The integration of this technology will allow for clinicians to monitor potentially catastrophic events and decrease mortality and lengths-of-stay, before they even occur resulting in better patient outcomes.
NKDHS expects to strengthen its technical development capabilities by combining its core human machine interface (HMI) technology with AMP3D’s algorithms and software technology. The combination of the two companies’ technologies fortifies NKDHS’ digital health ecosystem and compliments their portfolio, expanding the possibilities of their digital health offerings.
“We’re creating a digital health focused ecosystem of care,” said Harsh Dharwad, president and CEO of Nihon Kohden Digital Health Solutions Inc. “The future of healthcare lies within the utilization of data driven applications to predict onset clinical conditions, this acquisition makes us pioneers in the transformation of the industry.”